Mast cells promote homeostasis by limiting endothelin-1-induced toxicity

Marcus Maurer, Jochen Wedemeyer, Martin Metz, Adrian M. Piliponsky, Karsten Weller, Devavani Chatterjea, David E. Clouthier, Masashi M. Yanagisawa, Mindy Tsai and Stephen J. Galli ()
Additional contact information
Marcus Maurer: Beth Israel Deaconess Medical Center and Harvard Medical School
Jochen Wedemeyer: Beth Israel Deaconess Medical Center and Harvard Medical School
Martin Metz: Beth Israel Deaconess Medical Center and Harvard Medical School
Adrian M. Piliponsky: Stanford University School of Medicine
Karsten Weller: Universität Mainz
Devavani Chatterjea: Stanford University School of Medicine
David E. Clouthier: Cellular and Craniofacial Biology, University of Louisville
Masashi M. Yanagisawa: University of Texas Southwestern Medical Center at Dallas
Mindy Tsai: Beth Israel Deaconess Medical Center and Harvard Medical School
Stephen J. Galli: Beth Israel Deaconess Medical Center and Harvard Medical School

Nature, 2004, vol. 432, issue 7016, 512-516

Abstract: Abstract Endothelin-1 (ET-1) is a 21-amino-acid peptide, derived from vascular endothelial cells, with potent vasoconstrictor activity1. ET-1 has been implicated in diverse physiological or pathological processes2,3, including the vascular changes associated with sepsis2,3,4,5. However, the factors that regulate ET-1-associated toxicity during bacterial infections, or in other settings, are not fully understood2,3,4,5. Both the pathology associated with certain allergic and autoimmune disorders6,7, and optimal host defence against bacterial and parasitic infections8,9,10 are mediated by mast cells. In vitro, mast cells can produce ET-1 (ref. 11), undergo ET-1-dependent and endothelin-A receptor (ETA)-dependent activation12,13, and release proteases that degrade ET-1 (ref. 14). Although the potential relationships between mast cells and the ET-1 system thus may be complex, the importance of interactions between ET-1 and mast cells in vivo is obscure. Here we show that ETA-dependent mast-cell activation can diminish both ET-1 levels and ET-1-induced pathology in vivo, and also can contribute to optimal survival during acute bacterial peritonitis. These findings identify a new biological function for mast cells: promotion of homeostasis by limiting the toxicity associated with an endogenous mediator.

Date: 2004
References: Add references at CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
https://www.nature.com/articles/nature03085 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:432:y:2004:i:7016:d:10.1038_nature03085

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/nature03085

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().